Nonhomologous end-joining (NHEJ) of DNA doublestrand breaks (DSBs) entails two principal mechanisms: modification of DNA ends prior to ligation (error-prone rejoining) or precise ligation without modification if the DNA ends are complementary (error-free repair). Errorprone rejoining is mutagenic, because it can lead to destruction of coding sequence or to chromosomal aberrations, and therefore must be tightly regulated. Previous studies on the role of the p53 tumor suppressor in the regulation of NHEJ have yielded conflicting results, but a rigorous analysis of NHEJ proficiency and fidelity in a purely chromosomal context has not been carried out. To this end, we created novel repair plasmid substrates that integrate into the genome. DSBs generated by the ISceI endonuclease within these substrates were repaired by either error-prone rejoining or precise ligation. We found that the expression of wild-type p53 inhibited any repair-associated DNA sequence deletion, including a more than 250-fold inhibition of error-prone rejoining events compared to p53-null cells, while any promoting effect of p53 on precise ligation could not be directly evaluated. The role of p53 in NHEJ appeared to involve a direct transactivation-independent mechanism, possibly restricting DNA end-modification by blocking the annealing of single strands along flanking stretches of microhomology. The inhibition of error-prone rejoining by p53 did not apply to the rejoining of DSBs induced by ionizing radiation. In conclusion, our data suggest that p53 restricts the mutagenic effects of NHEJ without compromising repair proficiency or cell survival, thereby maintaining genomic stability.
Introduction
DNA double-strand breaks (DSB) are the most critical form of DNA damage that may result in loss or rearrangement of genomic material and thereby lead to mutations, genomic instability, cancer development, or cell death (Dikomey et al., 1998; Pfeiffer et al., 2000; Hoeijmakers, 2001; Willers et al., 2004) . DSBs arise spontaneously during normal cell metabolism but can also be induced by DNA damaging agents, such as ionizing radiation (IR). Two principal DSB repair pathways have been identified: homologous recombination (HR) and nonhomologous endjoining (NHEJ). DSB repair by HR requires an undamaged template that contains a homologous DNA sequence, typically on the sister chromatid in the S or G2 phase of the cell cycle. In contrast, NHEJ of two double-stranded ends does not require an undamaged partner and does not rely on extensive homologies between the recombining ends (Lieber et al., 2004) . NHEJ is active in all cell-cycle phases and is thought to repair the majority of DSBs. Defects in the NHEJ pathway cause increased cell death secondary to DSBs generated by IR or restriction endonucleases (Chang et al., 1993; Rogers-Bald et al., 2000) . Additionally, defective or deregulated NHEJ may result in chromosomal aberrations, genomic instability, and ultimately contribute to cancer development (Hoeijmakers, 2001; Willers et al., 2004) .
NHEJ can be an error-free or error-prone process, which is in part determined by different types of DNA ends. Complementary cohesive ends such as typically generated by restriction endonucleases can be rejoined in an error-free manner by precise ligation. This process may require only some components of the NHEJ pathway, such as the end-binding Ku proteins and the XRCC4-Ligase IV complex (Lieber et al., 2004) . In contrast, the rejoining of noncompatible DNA ends requires end-processing and thus additional factors that include nuclease and polymerase activity. The Artemis/ DNA-PKcs complex has been proposed to function as a nuclease while the polymerases likely include Pol l and m (Mahajan et al., 2002; Lee et al., 2004; Lieber et al., 2004) . Thus, precise ligation and error-prone rejoining of DSBs may not represent two distinct subpathways of NHEJ but rather reflect requirements for different components of the established NHEJ protein complexes (Lieber et al., 2004) .
NHEJ is commonly regarded an error-prone process due to the occurrence of end-processing (Allen et al., 2003; Lin et al., 2003; Lieber et al., 2004) . This frequently involves the alignment of overhanging ends by pairing along nucleotides of 1-4 bp microhomology that flank the break site, followed by gap filling or trimming of a few bases and subsequent ligation. The repair of IR-induced DSBs is generally error-prone because IR destroys sequence information by causing complex DNA damage sites (Henner et al., 1983; Willers et al., 2004) , thereby requiring end-modification prior to rejoining. It is largely unknown which regulatory proteins control the extent of DNA sequence alteration during repair, by limiting the size of deletions or by promoting error-free over error-prone repair whenever the nature of the DNA ends allows. Any increase in the extent of end-processing destroys additional sequence that may be coding or regulatory, or may lead to chromosomal aberrations via the creation of recombinogenic DNA ends. Thus, NHEJ processes must be tightly regulated to limit their mutagenic outcome.
The p53 tumor suppressor plays a pivotal role in the maintenance of genomic stability and suppression of cellular transformation. Accordingly, wild-type p53 function is disrupted by genetic mutations or inactivation of upstream or downstream pathways in the majority, if not all, human cancers (Levine, 1997; Sionov and Haupt, 1999) . p53 has emerged as a multifunctional regulator, which is at the center of several pathways involved in cell-cycle control, apoptosis and DNA repair (Dahm-Daphi, 2000; Meek, 2004) . Many functions of p53 are mediated by transcriptional activation of downstream targets such as p21. We and others have recently defined a transactivation-independent role of p53 in the suppression of HR processes, which may serve to prevent genomic instability (Saintigny et al., 1999; Willers et al., 2000; Akyu¨z et al., 2002; Boehden et al., 2003; Romanova et al., 2004) . Importantly, p53 downregulates the homology-mediated repair of chromosomal DSBs, as generated by the rare-cutting I-SceI endonuclease (Akyu¨z et al., 2002; Boehden et al., 2003) . However, studies on the role of p53 in the regulation of NHEJ processes have yielded conflicting observations ranging from a promotion of NHEJ to suppressive effects to no effect (Bill et al., 1997; Yang et al., 1997; Tang et al., 1999; Willers et al., 2001; Akyu¨z et al., 2002; Okorokov et al., 2002; Lin et al., 2003) . Many of these inconsistent results may be either due to the nonphysiologic nature of the assay systems employed that have included in vitro end points or extrachromosomal components, or due to the inability to detect an unselected spectrum of NHEJ events.
In this paper, we tested the hypothesis that p53 modulates nonhomologous repair of site-specific chromosomal I-SceI breaks. Plasmid substrates designed to detect repair by NHEJ with or without modification of DNA ends were chromosomally integrated in p53-null mouse embryonic fibroblasts (MEFs). Expression of wild-type p53 caused a more than 250-fold reduction in the error-prone rejoining of I-SceI breaks. By contrast, the rejoining of IR-induced DSBs was not affected. These data support the evolving role of p53 as a central regulator of recombinational processes that maintains genomic stability not only by downregulating inappropriate homology-mediated genetic exchanges but also by limiting the mutagenic effects of error-prone NHEJ.
Results

Design of novel repair plasmid substrates to measure chromosomal NHEJ
To measure NHEJ of chromosomal breaks, we have created a pair of repair plasmid substrates that integrate into the genome, designated pPHW1 and pPHW2. Each substrate contains an artificial translational start sequence (ATG art ) inserted between an early SV40 promoter and the bacterial gpt gene (Figure 1a) . The associated open reading frame (ORF) is shifted by 1 bp against the downstream gpt ORF and is dominant over the gpt start site (ATG gpt ), hence, preventing gpt translation. Two I-SceI recognition sites flank the ATG art site. Simultaneous cleavage at both I-SceI sites results in loss, that is, pop-out, of ATG art with reconstituted translation of the original gpt ORF, thereby allowing the detection of recombinants as colonies growing in XHATM selection medium ( Figure 1a) . Alternatively, error-prone rejoining at a single I-SceI site may lead to deletions that affect ATG art without creating to a pop-out event. By contrast, precise ligation at a single I-SceI site, which does not alter the parental DNA sequence, cannot be detected directly. The two substrates are identical except for the orientation of the two I-SceI recognition sites. In pPHW1, these are placed in direct repeat orientation producing complementary 3 0 overhangs that can be a substrate for precise ligation after a pop-out event. In pPHW2, the upstream I-SceI site is inverted, resulting in noncomplementary ends after a pop-out and thereby forcing sequence alteration prior to ligation (error-prone rejoining).
High frequency of repair of chromosomal I-SceI breaks by NHEJ in p53-null cells Each of the repair plasmid substrates was integrated into a chromosome of untransformed p53-null MEFs (Willers et al., 2000) . Multiple clones with single-copy plasmid integrants were tested. Following transient transfection of an I-SceI expression vector or a control, cells were grown in XHATM-containing selection medium. We observed high frequencies of XHATM-resistant colony formation indicating DSB repair, ranging from 1.5 Â 10 À5 to 8 Â 10 À3 (Figure 1c ).
Of note, the substrate with complementary ends (pPHW1) does not appear to be a preferred substrate over pPHW2, which offers noncomplementary ends, indicating that DNA ends that require processing for repair are not disadvantageous. Two representative clones carrying either pPHW1 or pPHW2 (no. 24 or no. 35, respectively) were selected, XHATM-resistant colonies were expanded, and genomic DNA was analysed. In cells with pPHW1, approximately 50% of detected events resulted from simultaneous I-SceI breaks with pop-out of the ATG art site (Figure 2 ). In line with the observations made in Figure 1c , only half of the repair products resulted from precise ligation of the complementary ends. The other repair junctions reflected error-prone rejoining characterized by endprocessing and deletion of sequence ranging from 2 to In 39% of all cases, we detected error-prone rejoining at the downstream I-SceI cleavage site without accompanying pop-out ( Figure 2 ). In all except one of these products, XHATM resistance was a result of small deletions (1-19 bp) that brought the ATG art in-frame with ATG gpt , thereby producing an N-terminally extension of 13 amino acids. Sequence deletion extending upstream into ATG art was not detected. In one case, a 2 bp deletion created an immediate in-frame stop codon and presumptive retranslation at ATG gpt . In another two cases, we found sequence capture events, a repair type also reported by others (Allen et al., 2003) . In contrast to pPHW1, rejoining in pPHW2 following popout of ATG art required end-processing of the noncomplementary ends and this mostly consisted of small deletions of 1-4 nucleotides ( Figure 2 and data not shown). Similarly to pPHW1, in 33% of cases, there was detectable error-prone rejoining at the downstream I-SceI site while the upstream I-SceI site remained unaffected. Of note, the detected repair events at the downstream I-SceI site likely reflect an underestimate of the total frequency of all repair events at either of the two cleavage sites because we cannot detect: (i) small deletions at the upstream I-SceI site that do not destroy ATG art and (ii) deletions of 3 bp or n Â 3 bp since these do not change the relative position of ATG art to ATG gpt .
Derivation of cell clones with stable expression of exogenous wild-type p53
To study the effects of p53 on DSB repair in isogenic cell pairs, we utilized the Flp recombinase system for stable expression of exogenous in p53-null MEF clones that carry pPHW1 or pPHW2 (clones no. 24 and 35, Figure  1c and 2). In addition to wild-type p53, we chose to test two tumor-derived p53 mutants harboring either the V143A or the R273H amino-acid exchange. An advantage of the Flp system is that all p53 variants are expressed from the same chromosomal integration site. Each of the two p53-null clones was stably transfected with a plasmid bearing two Flp recognition sites and a LacZ gene (see Material and methods). The empty control vector, the R273H mutant or the V143A mutant were successfully targeted to the chromosomal Flp site at a frequency of approximately 1 Â 10
À3
. In contrast, transfection of the wild-type p53 expression vector initially did not result in colony formation with most cells killed within 2 weeks. Eventually, 55 colonies out of 10 7 plated cells could be harvested and expanded. Out of these, only two clones proved to express low levels of p53, one for each of the two repair plasmid substrates.
Functional wild-type p53 status was verified by IRinduced protein induction and transactivation of p21 Figure 3 (a) Western blot of MEF clones (raised from clone no. 24) expressing wild type (wt) or mutant p53 (143, 273) with or without irradiation (6 h after 2 Gy). MCF7 cells expressing endogenous wt p53 were used as controls. Blots were probed for p53 (top) or p21 (bottom). Note that four times more wild-type protein was loaded compared to the MEF extracts containing the p53 mutants. Also, note that the murine p21 protein is smaller than human p21. ( Figure 3a ). In contrast, the clones expressing V143A or R273H protein showed much higher protein levels that were not inducible by IR and showed no transcriptional activation of p21 ( Figure 3a and data not shown). Consistent with the low expression level of wild-type p53, we observed no significant suppression of cell growth compared to the cells transfected with V143A, R273H or the control vector (data not shown). Clones bearing mutated p53 protein are known to arise over time in tissue culture since they gain growth advantage over the parental population expressing wild-type p53. However, the cell populations under study retained wild-type status over at least 15 passages. Next, we wished to rule out the presence of any major nonspecific suppressive or toxic effects of wild-type p53 that could have the potential to bias our plasmid-based repair assay. The detection of repair events critically depends on the capability of cells to form colonies after I-SceI vector transfection. Figure 3b indicates that lowlevel expression of wild-type p53 did not cause a general suppression of colony growth. The cell plating efficiencies in nonselective medium after I-SceI transfection differed between clones, but these differences did not correlate with cellular p53 status. In support of this, apoptosis was also unlikely to have biased repair in our experiments since neither growth kinetics nor cell attachment was appreciably affected upon expression of wild-type p53 (data not shown). The rejoining frequency of DSBs is influenced by the rate of I-SceI break induction, which is determined by the levels of ISceI endonuclease. Wild-type p53 can repress transcription from CMV promoters, which is relevant for the pCMV-I-SceI vector used here (2). We transiently transfected plasmids that carried either the GFP or luciferase reporter genes under control of a CMV promoter. For the GFP reporter, on average 48% of cells expressing wild-type p53 showed green fluorescence compared to 58-89% for the other cell clones (Figure 3c ). Similar results were obtained when using the luciferase reporter (data not shown). Finally, we wished to rule out any major DSB rejoining defect in cells expressing wild-type p53. The rejoining of restriction-enzyme-cleaved complementary or noncomplementary ends in extrachromosomal plasmid substrates was impaired only by approximately two-fold in cells with wild-type p53 (Figure 3d ). We concluded that the established wild-type p53 clones were suitable for the plasmid-based DSB rejoining assays.
The frequencies of error-prone rejoining at a single I-SceI site and of pop-out-associated repair are reduced in cells with wild-type p53
Cells carrying pPHW1 or pPHW2 and either one of the p53 variants were transfected in parallel with the I-SceI expression vector (Figure 4a ). Repair frequencies following growth in selective XHATM medium were determined as in Figure 1c . For each data set, transient transfection efficiencies were monitored in parallel using a GFP-expressing vector (data not shown). For cells transfected with the control vector or the R273H mutant, NHEJ frequencies were found to range between 5 Â 10 À4 and 1 Â 10 À2 of the cell population. In striking contrast, expression of wild-type p53 suppressed the formation of XHATM-resistant colonies below the detection limit of 8 Â 10 À7 for both pPHW1 and pPHW2 clones, representing an inhibition of several orders of magnitude of all repair events detectable in p53-null cells. This result was reproducible in eight independent experiments. In Figure 2 , we showed that XHATM resistance in p53-null cells was due to two principal types of repair events: (i) Pop-out events with subsequent precise ligation or error-prone rejoining of the generated ends. For example, the frequency of pop-out events was estimated at 2.7 Â 10 À4 for pPHW1.
(ii) Error-prone rejoining of a single DSB at the downstream I-SceI site, which occurred at 2.0 Â 10
À4
. Therefore, in the presence of wild-type p53, both repair types were inhibited by at least 250-fold to a level of 8.0 Â 10 À7 . Importantly, the specific inhibitory effect of p53 on NHEJ processes was corroborated by the observed reduction of NHEJ in the presence of the p53-V143A mutant (Figure 4a ), which has been previously shown to be also a suppressor of HR events (Willers et al., 2000) . This mutant is unable to upregulate p21 (Figure 3a and data not shown), suggesting that NHEJ inhibition was independent of transcriptional activity (even though the magnitude of effect on NHEJ was smaller than for In cells expressing the V143A mutant, this was reduced to 57% (n ¼ 7) (P ¼ 0.038, mid-P-value, two-sided, Fisher exact test)
Regulation of NHEJ by p53 J Dahm-Daphi et al wild-type p53). This is consistent with the regulatory role that p53 plays in HR and base excision repair (Saintigny et al., 1999; Willers et al., 2000; Offer et al., 2001; Boehden et al., 2003) .
As noted, p53 suppressed detectable rejoining of a single DSB at the downstream I-SceI cleavage site, thus indicating an inhibition of error-prone repair of complementary DNA ends. By contrast, we could not directly assess the effect of p53 on the error-prone repair of noncomplementary ends because pop-out events in pPHW2 were restricted in the presence of wild-type p53. To address this question, we took advantage of the partially suppressive effect of the p53-V143A mutant, which permitted the analysis of individual XHATMresistant recombinants. The rejoining of noncomplementary ends is typically mediated by the annealing of processed ends along short stretches of microhomologies flanking the break site. When studying the endjoining junctions between noncomplementary ends in pPHW2, we found that in p53-null MEFs 100% of the repair events were mediated by annealing along directly adjacent microhomologies of 1 or 2 bp (Figure 4b and data not shown). In contrast, in the presence of p53-V143A, the usage of microhomologies to form the junction was significantly reduced at 57%. These findings are consistent with the idea that p53 restricts the processing of DNA ends perhaps by destabilizing the alignment of single-stranded DNA ends along microhomologies or mismatches.
p53 does not affect DSB rejoining following treatment with IR
If p53 suppresses error-prone NHEJ, as could be inferred from our plasmid-based data (Figure 3c ), the repair of IR-induced DSBs, which is generally errorprone, should be highly inefficient in cells expressing wild-type p53. For all cell lines under study, DSB repair kinetics following treatment with IR was assessed by constant-field gel electrophoresis (CFGE). Repair capacity was found to be similar among all analysed clones (Figure 5a ). We did detect clonal heterogeneity but there was no correlation with the cellular p53 status. The number of residual DSBs was higher in the clones carrying pPHW2 (originating from clone no. 35) than in the cells with pPHW1 (no. 24) for reasons unknown. Within the clones carrying pPHW1 the rejoining curves apparently deviate, which is due to a small difference in the number of residual breaks observed, that is, ranging between 1.5 and 5-Gy equivalent. The rejoining kinetics per se was not altered. Similar to the CFGE results, cellular p53 status did not significantly influence clonogenic cell survival after IR treatment, which is mainly determined by the overall NHEJ capacity (Figure 5b ).
Discussion
We have developed a plasmid-based chromosomal assay to monitor NHEJ of site-specific DSBs. In p53-deficient MEFs, we were able to detect repair events arising by several mechanisms (Figure 1c With regard to error-prone rejoining, our assay appears to represent a chromosomal repair spectrum not influenced by the applied selection pressure, which is supported by recent previous reports (Allen et al., 2003; Guirouilh-Barbat et al., 2004) .
We observed a reduction of several orders of magnitude in the formation of XHATM-resistant colonies in cells with wild-type p53 compared to p53-null cells or cells expressing the p53-R273H mutant (Figure 4a ). It was unlikely that this influence of wildtype p53 represented unspecific suppressive or toxic effects, as addressed in extensive control experiments (Figure 3 ). In addition, the p53-V143A mutant behaved similarly to wild-type p53 in terms of its repair phenotype (Figure 4a ), despite the inability to act as a transcription factor for p21. Considering the different repair types resulting in XHATM resistance (Figure 2) , we conclude that p53 downregulated not only error-prone rejoining at a single I-SceI site but also the formation of pop-out events following simultaneous I-SceI cleavage (irrespective of the type of the How does p53 exert these effects? Interestingly, the reported downregulation of HR by p53 is possibly mediated by recognition of mismatches followed by resolution of Holliday-type DNA structures (Dudenhoffer et al., 1998; Skalski et al., 2000) . Thus, a similar mismatch-based mechanism for repair suppression may apply to the regulation of NHEJ. We hypothesize that p53 can resolve NHEJ intermediates to preserve the original DNA sequence, illustrated in Figure 6 . Following I-SceI cleavage (Figure 6a ), both ends may be degraded until two matching bases are freely exposed (Figure 6b ). p53 may have an impact on this process directly by its own or by modulation of the WRN or perhaps the DNA-PK/Artemis exonuclease activity (Mummenbrauer et al., 1996; Huang, 1998; Brosh et al., 2001; Ma et al. 2002) , but further studies are needed to address these possibilities in particular as to whether p53 can directly act as repair protein on DNA in vivo. Alternatively (Figure 6c ), the single-stranded ends can be unwound due to thermodynamic instability or helicase activity until base pairing occurs and resulting flaps are resected. A third mechanism (Figure 6d ) involves the formation of a more complex recombination intermediate containing several base pairings as well as mismatches that need to be properly corrected. As the postulated overlap intermediates (Figures 6c, d) contain only a few base pairings, it has been suggested that alignment proteins may be used to stabilize these intermediates (Pfeiffer et al., 1994) . Direct interference of p53 with such an alignment complex may explain the observed suppression of microhomologyusage during rejoining of noncomplementary DNA ends ( Figure 4c ). As p53 co-localizes with Mre11 in subnuclear foci (Carbone et al., 2002) , an attractive hypothesis is that modulation of the activity of the Mre11 complex by p53 could affect end-processing or alignment along microhomologies. p53 also co-localizes or interacts with other proteins that have putative functions in NHEJ, such as ATM, BRCA1, DNA-PK, WRN helicase and 53BP1 (Achanta et al., 2001; Brosh et al., 2001; Iwabuchi et al., 2003; Lieber et al., 2004; Meek, 2004; Zhang et al., 2004) , so the role of p53 in the direction of NHEJ is likely complex.
In addition to the postulated binding of p53 to NHEJ intermediates, it is likely that other mechanisms are operative. For example, p53 may actively inhibit any pop-out events or promote the direct ligation of complementary ends. The latter notion is consistent with a recent study by Lin et al. (2003) , who studied chromosomal DSB repair in established MEFs with endogenous wild-type p53. Upon inactivation of p53 with the chemical inhibitor pifithrin-a, a five-to 10-fold reduction of precise ligation events following a pop-out between two I-SceI sites oriented in tandem (similarly to pPHW1) was found. These authors speculated that by facilitating precise ligation and suppressing HR, p53 may afford the cell maximum protection against DSBinduced alterations. However, in contrast to our study, mutagenic rejoining events were not significantly affected by the activity of p53 in that system (less than two-fold). It seems possible that the inactivation of p53 by pifithrin-a versus allelic deletion of p53, as in our study, have different consequences with regard to NHEJ regulation.
Of note, in the extrachromosomal context, p53 suppressed the rejoining of both complementary and noncomplementary ends to a similar degree (Btwo-fold) (Figure 3d) . The physiologic significance of this suppression is unclear but does not seem to reflect transrepressive effects of wild-type p53, as the rejoining data are normalized to uncleaved plasmid and an internal control. Comparison of the extrachromosomal and intrachromosomal results indicates that the inhibitory effect of p53 on error-prone rejoining is far more pronounced in the context of high-order chromatin. In the extrachromosomal context, where the doublestranded plasmid ends are not in close proximity, p53 may not act preferentially on either type of ends, that is, complementary versus noncomplementary ends.
The genetic determinants of nonhomologous repair of I-SceI breaks have not been fully established. Recent reports showed for CHO and yeast cells (Ma et al., 2003; Guirouilh-Barbat et al., 2004) , Ku70/80 controlled the precise ligation of I-SceI breaks in CHO cells while the rejoining of noncohesive ends was not affected. However, other data implicate the Ku proteins and DNAPKcs in both error-free and error-prone DSB repair (Bryant et al., 1987; Chang et al., 1993; Pierce et al., 2001; Lieber et al., 2004) . It remains to be established which regulatory factors dictate the choice between error-free and error-prone rejoining of DNA ends that are a substrate for either repair type. Our data suggest that p53 may be part of such a regulation.
Interestingly, the effect of p53 on I-SceI break repair did not apply to the rejoining of IR-induced DSBs (Figure 5a ) (DiBiase et al., 1999; Bo¨hnke et al., 2004) . At least two possible explanations can be proposed. IR induces mostly DSBs containing 'dirty' DNA ends, that is, phosphoglycolates or 3 0 -phosphate groups (Henner et al., 1983) , which are not a substrate for p53. Alternatively, the chromatin structure flanking an IRor I-SceI-induced break could differ, which might impact on the accessibility for proteins including p53. Consistent with the DSB rejoining data, cellular survival after exposure to IR was independent of p53 status (Figure 5b) . Previously, similar results have been found for untransformed MEFs, which do not undergo apoptosis (Powell et al., 1995) . We believe that radiosensitization frequently observed with p53 transgene expression may only be achieved if the protein is highly overexpressed. However, in our study, we established low p53 expression levels, which may not impact on overall DSB repair capacity or radiation resistance.
How do we reconcile the different effects of p53 with regard to NHEJ of site-directed versus IR-induced DSBs? We propose a common theme in which p53 limits any type of DNA sequence loss as long as it is compatible with cell survival: Error-prone rejoining is inhibited if precise ligation is an available alternative repair pathway, which does not apply to IR-induced breaks. Microhomology-usage is downregulated as this typically involves deletion of sequence. Pop-out events with appreciable mutagenic potential may be inhibited by an unknown mechanism and irrespective of the type of DNA ends generated. The downstream mechanisms by which p53 exerts these broad effects remain to be elucidated.
What is the physiological relevance of the inhibitory effect of p53 on error-prone NHEJ? Cells suffer a considerable number of DSBs during each division cycle (Vilenchik and Knudson, 2003) . Many of these breaks may have complementary ends arising either from thermal fluctuations, spontaneous hydrolysis or topoisomerase II cleavage (Liu et al., 1983; Vilenchik and Knudson, 2003) . In addition, excision repair of two nearby damaged bases (base excision repair) will result in single-stranded 3 0 -OH and 5 0 -P overhangs that do not contain mismatches (Dahm-Daphi et al., 1997; Izumi et al., 2003) . p53 could directly or indirectly downregulate error-prone repair of these breaks, thereby reducing their recombinogenic potential. Defective or deregulated NHEJ has the potential to destabilize the genome, as shown for Ku80 or LigaseIV/XRCC4 deficiency (Difilippantonio et al., 2000; Ferguson et al., 2000; Gao et al., 2000) . Typical structural aberrations are symmetric or asymmetric translocations. We acknowledge that our assay does not allow us to monitor the fate of DSBs in terms of interchromosomal endjoining. However, previous studies have not detected any appreciable frequency of chromosomal aberrations arising from I-SceI cleavage at a single chromosomal integration site in cells with intact DNA-PK-dependent NHEJ (Richardson et al., 1998; Rogers-Bald et al., 2000) . We therefore do not believe that interchromosomal end-joining is a significant alternative pathway to the intrachromosomal rejoining events we have observed. A major task of future studies will be to dissect which chromosomal aberrations in p53-deficient cells are due to defective regulation of NHEJ and HR, and further, how repair interferes with p53-dependent apoptosis and cell-cycle checkpoint control to preserve genomic stability.
In conclusion, the combined data suggest a model in which p53 plays a central role in the cellular response to DNA damage, where it may modulate the choice between several available DSB repair mechanisms. We hypothesize that p53 functions by reducing the mutagenic effects of nonhomologous repair, for example, by promoting error-free over error-prone end-joining whenever possible.
Materials and methods
Cell system
Immortal MEFs (10.1 clone) that lack both alleles of p53 have been described previously (Willers et al., 2000) . Stable exogenous expression of wild-type or mutant p53 was achieved by using the Flp recombinase system, following the purchaser's protocol (Flp-Int, Invitrogen). In pFRT/lacZeo, which contains the recognition site for the Flp recombinase, the zeocin resistance gene was replaced with a neomycin resistance gene. In total, 1 mg of the pFRT/lacNeo was electroporated (Gene-Pulser II, BioRad, 250 V, 900 mF) into 10 6 MEFs carrying either one of the recombination substrates (pPHW1 or pPHW2). Clones raised in G418-containing selection medium grown screened for b-galactosidase expression (bGalactosidase Assay System, Promega) and clones with intermediate expression levels were subjected to further transfection with one of three pcDNA5/FRT plasmid derivatives, into each of which a different human p53 cDNA had been cloned, that is, wild-type p53, p53-V143A, or p53-R273H. The two respective point mutations (GTG-GCG and CGT-CAT) had been generated by site-directed mutagenesis (Quick-Changet, Stratagene). The pcDNAp53/ FRT plasmids were cotransfected with pOG44 expressing the Flp recombinase. Integration into the FRT sites was selected for by hygromycin, and individual clones were expanded and tested. For immunoblotting, protein was extracted either immediately or 5 h after irradiation with 6 Gy or mock treatments. Proteins were immunoblotted according to standard procedures (Bo¨hnke et al., 2004) and probed with either anti-p53 antibody (DO7, Novocastra) or anti-p21 (EA10, Oncogene).
Recombination substrates
For generation of pPHW1 and pPHW2 (Figure 1 ), pSV2-gpt (Willers et al., 2000) was first cleaved at the BglII and KpnI sites to remove the intrinsic stop codons downstream of the BglII site. A new 154-bp BglII-KpnI fragment was generated by PCR using primers GCGAGATCTGGCTGGGACACTT CACATGA and ACCCGGTACCAGACCGCCAC, and inserted into pSV2-gpt, generating pSV2-gpt-2. An oligonucleotide containing the sequence HindIII-XhoI-Kozak/ATG-I-SceIBglII was created by annealing GACCAAGCTTGCCCTCGA GCCATGGATTACCCTGTTATCCCTAGATCTCCGT and ACGGAGATCTAGGGATAACAGGGTAATCCATGGCT CGAGGGCAAGCTTGGTC, and inserted into HindIIIBglII-cleaved pSV2-gpt-2, generating pSV2-gpt-3. The second upstream I-SceI site was inserted into pSV2-gpt-3 via an oligonucleotide encoding HindIII-I-SceI-XhoI, made by annealing CCCAAGCTTGCGCCCATTACCCTGTTATCC CTACTCGAGCCGT and ACGGCTCGAGTAGGGATAA CAGGGTAATGGGCGCAAGCTTGGG, thereby generating pSV2-gpt-4a. In a parallel approach for generation of pSV2-gpt-4b, the coding sequence of the I-Sce site in the oligonucleotide was flipped (not shown). pPHW1 and pPHW2 were generated from pSV2-gpt-4a and pSV2-gpt-4b, respectively, by insertion of a puromycin resistance gene. For this approach, the puromycin ORF was removed from pHWI (Willers et al., 2000) as a HindIII-EcoRI fragment and inserted into pcDNA3.1neo. The puromycin gene under the control of the CMV promoter was removed as an MfeI-PvuII cassette and inserted into SwaI-EcoRI cleaved pSV2-gpt-4a or -4b. In pPHW1 and pPHW2, the new sequence that defines the artificial ORF reads as HindIII-I-SceI-XhoI-GCCATGG-ISceI-BglII. The associated polypeptide (31 amino acids) terminates within the gpt ORF (nucleotide 50). The new plasmids are 5.5 kb in size and can be linearized at the unique PvuI site. All PCR-generated fragments and cloning end products were sequenced.
Reporter plasmids and extrachromosomal rejoining assay
For control of transfection efficiency in parallel to transfection of the I-SceI vector, 30 mg of pEGFP-N1 (Clontech) was used.
At 48 h after electroporation, green fluorescence was measured in a FACScan (Becton Dickinson). Extrachromosomal plasmid rejoining was measured essentially as described (Tang et al., 1999) . The pCMV-GFL plasmid (generous gift from Heiner Ku¨pper) expressed a luciferase-green fluorescent fusion protein. pCMV-GFL was linearized either by HindIII or by Xho/HindIII separating in both cases the promoter from the ORF. In total, 30 mg of the gel-purified plasmid was electroporated and after 48 h proteins were extracted and luciferase activity (relative light units, RLU) was determined according to the manufacturer's protocol (Luciferase Assay System, Promega; Sirius luminometer, Berthold, Germany). In parallel, the uncleaved circular plasmid was transfected as positive control and linearized plasmid lacking the CMV promoter as negative control. Relative end-joining activity was defined as RLU of linearized plasmid divided by the RLU of circular plasmid. pEGFP-N1 (Clontech) as well as pCMV-GFL were utilized in transient transfection assays (30 mg for each transfection) to monitor the transrepressive effect of wild-type p53 on the CMV promoter.
Chromosomal NHEJ assay pPHW1 and pPHW2 were linearized at the PvuI site and 0.5 mg of either plasmid was electroporated into 10 6 cells. Cells were grown for 3 weeks in selective medium (2.5 mg/ml puromycin, Sigma) until approximately 60 colonies could be isolated and expanded. Plasmid integration and structure were characterized by extensive PCR analysis, including the primer pair ATGTTGCAGATCCATGCACG and AATACGACGCCA-TATCCC that amplified a 400-bp fragment of the gpt gene. In total, 3 Â 10 6 cells carrying either one of the recombination substrates were electroporated with 50 mg of pCMV-I-SceI or a control plasmid (Zhang et al., 2004) . To allow for I-SceI expression and recombination to proceed, cells were grown for 48 h in nonselective medium. Cells were then replated at appropriate densities between 10 5 and 10 6 per 75 cm 2 , and after 16 h the medium was changed to XHATM (xanthine, hypoxanthine, aminopterin, thymidine and mycophenolic acid at 10, 13.6, 0.17, 3.87 and 10 mg/ml respectively; all Sigma). Cells were grown for 2-3 weeks with medium exchange three times per week. Control cells were grown in puromycin without XHATM. The NHEJ frequency was derived from the number of XHATM-resistant colonies corrected for plating efficiency in nonselective medium.
Clonogenic cell survival and DSB rejoining following irradiation
Subconfluent cell populations were irradiated with X-ray doses of up to 8 Gy and seeded for colony formation as described (El-Awady et al., 2003) . Confluent cells were irradiated with up to 50 Gy and the induction and rejoining of DSBs were measured by constant-field gel electrophoresis as described (ElAwady et al., 2003) . A DSB induction curve (not shown) was used for calibration of the repair kinetics.
Statistics
Experiments were repeated three times and the mean with standard error (7s.e.m.) calculated unless noted otherwise. Statistical analysis, data fitting and graphics were performed by means of the Prism 3.0 computer program (GraphPad Software, San Diego, USA).
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